文献速递抗栓抗凝管理特殊人群用药药物不良反应与药物警戒

药师主导的电子访视项目在糖尿病患者和抗凝管理中的实施与评估

Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home.
PubMed 文献 · Am J Health Syst Pharm · 2018-04-13

该回顾性前后对照研究评估了药师通过电子访视对未控制的糖尿病成人患者和进行患者自我检测(PST)监测INR的华法林治疗患者的质量、财务和满意度结局。结果显示华法林组INR达标率从62.5%升至72.7%(p=0.07),极端INR值频率从4.8%降至0.01%(p=0.01);糖尿病组糖化血红蛋白降低3.4个百分点(p<0.001),患者满意度中位得分为39/40。结论认为电子访视模型安全、有效且具有成本效益。

要点

  • 华法林PST患者经电子访视后极端INR值频率显著降低(4.8%→0.01%,p=0.01)。
  • 糖尿病电子访视组糖化血红蛋白降低3.4个百分点(p<0.001)。
  • 华法林组第一年每患者利润300美元,此后每年191美元;糖尿病组每患者利润100美元。

核心结论

  • 华法林监测的在线电子访视模型是实施PST的高效、安全且具有成本效益的方法。
  • 药师通过电子访视管理糖尿病(常结合面对面访视)在产生收入的同时显著改善临床结局。

研究设计与样本

  • 回顾性前后对照研究,纳入2组门诊患者:未控制的糖尿病成人患者和进行PST监测INR的华法林治疗成人患者。
  • 研究期间共36名患者参与电子访视项目。

主要发现

  • 华法林组INR达标百分比从入组前的62.5%增至72.7%(p=0.07)。
  • 华法林组极端INR值(<1.5或>5.0)频率从4.8%降至0.01%(p=0.01)。
  • 糖尿病组入组后5.7个月时糖化血红蛋白较基线降低3.4个百分点(p<0.001),他汀使用、阿司匹林使用和血压控制频率显著改善。
  • 患者满意度调查总体中位得分为39/40。

关键数值与推荐

  • 华法林组第一年每患者利润300美元,此后每年191美元;糖尿病组每患者利润100美元。

临床怎么用

  • 药师可通过电子访视模型管理华法林PST患者的INR监测,提高达标率并减少极端值。
  • 药师可通过电子访视(常结合面对面访视)管理未控制的糖尿病成人患者,改善血糖和血压控制。

局限性

  • 样本量较小(共36名患者),可能影响结果的普遍性。
  • 为回顾性前后对照设计,非随机对照,存在混杂因素可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Results of a study evaluating quality-of-care, financial, and patient satisfaction outcomes of pharmacist-conducted telehealth visits for diabetes management and warfarin monitoring are reported. METHODS: A retrospective pre-post study was conducted to determine the impact of an electronic visit (e-visit) program targeting 2 groups of outpatients: adults with uncontrolled diabetes and warfarin-treated adults performing patient self-testing (PST) for monitoring of International Normalized Ratio (INR) values. RESULTS: A total of 36 patients participated in the e-visit program during the 2-year study period. Among warfarin-treated patients, the percentage of INR values in the desired range increased relative to preenrollment values (from 62.5% to 72.7%, p = 0.07), and the frequency of extreme INR values (values of <1.5 or >5.0) decreased (from 4.8% to 0.01%, p = 0.01); the margin per patient was $300 during the first year and $191 annually thereafter. In the diabetes group, a decrease from baseline in glycosylated hemoglobin values of 3.4 percentage points was observed at 5.7 months after enrollment (p < 0.001), with significant improvements in frequencies of statin use, aspirin use, and blood pressure control; the margin was $100 per patient. The overall median patient satisfaction survey score was 39 of 40. CONCLUSION: An online e-visit model for warfarin monitoring was an efficient, safe, and cost-effective method for implementing PST. Pharmacist-led management of diabetes through e-visits, often in combination with in-person visits, generated revenue while significantly improving clinical outcomes.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Hawes EM, Lambert E, Reid A, et al. Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home. Am J Health Syst Pharm. 2018. PMID: 29654139. doi:10.2146/ajhp170174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。